Ichiro Abe. Efficacy and safety of low-dose ipragliflozin, a selective sodium glucose transporter 2 inhibitor, in patients with type 2 diabetes mellitus. ijamscr [Internet]. 2020 Aug. 6 [cited 2024 Apr. 29];4(3):376-82. Available from: https://ijamscr.com/ijamscr/article/view/283